---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-006197"
form_type: "8-K"
ticker: "KURA"
cik: "0001422143"
company_name: "Kura Oncology, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T01:53:23.043586+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Kura Oncology enters lease for new San Diego headquarters, 32,512 sq ft

## Summary
- Lease of 32,512 sq ft at 4930 Directors Place, San Diego, for new principal executive offices and R&D.
- Term 7 years 8 months, one 5-year extension option; monthly rent ~$183,693 first year, 3% annual increases.
- Rent abatement up to $2.4M and tenant improvement allowance up to $6.2M.
- Early termination right after 5.5 years with 12 months notice and 8 months rent penalty.
- Obligation includes base rent and additional rent for operating expenses, taxes, utilities.

## SEC filing metadata
- accession: 0001193125-25-006197
- form_type: 8-K
- ticker: KURA
- cik: 0001422143
- company_name: Kura Oncology, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/0001193125-25-006197-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1422143/000119312525006197/d875953d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-006197
- JSON: https://secwatch.observer/filing/0001193125-25-006197.json
- Plain text: https://secwatch.observer/filing/0001193125-25-006197.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.